Binex, Tongfang Rework Deal Amid Strained Korea-China Ties

With Tongfang Kontafarma's cancelation of an equity investment, Binex appears to have become the first South Korean biologics firm to be hit by an increasingly strained relationship between South Korea and China. The two companies will instead establish a Chinese joint venture.